This course has expired. View available courses.
Cardiovascular, Diabetes
After Metformin: The Newest Oral Antidiabetic Therapies and Cardiovascular Safety – Mainpro+
DURATION
PROFESSION
Physician
# OF CREDITS
1
ACCREDITATION
Mainpro+
EXPIRY DATE
2017-08-15
Learning objectives
- Describe the newest classes of oral antidiabetic therapy available in Canada and their role in the management of type 2 diabetes.
- Review the evidence for cardiovascular safety of the newest oral antidiabetic therapies.
- Examine the safety considerations when selecting an oral agent for the management of type 2 diabetes in patients with cardiovascular disease.